Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles Vincent Rajadurai

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Mcgill Journal of Medicine : MJM : an International Forum for the Advancement of Medical Sciences by Students|January 26, 2011
Cracking Cancer with CRKAbicumaran Uthamacumaran, Charles Vincent Rajadurai, Morag Park
Current Oncology (Toronto, Ont.)|November 26, 2024
Evaluating the Efficacy of Immunotherapy in Fragile Hospitalized PatientsCharles Vincent Rajadurai, Guillaume Gagnon, Catherine Allard, et al.
Current Oncology (Toronto, Ont.)|May 26, 2023
An Unconventional Regimen of Carboplatin and Paclitaxel in Metastatic Colorectal Carcinosarcoma: A Case Report and Review of LiteratureChangsu Lawrence Park, Charles Vincent Rajadurai, Tuyet Nhung Ton Nu, et al.
Breast Cancer Research : BCR|December 16, 2014
Breast cancer anti-estrogen resistance 3 inhibits transforming growth factor β/Smad signaling and associates with favorable breast cancer disease outcomesJimin Guo, Lucie Canaff, Charles Vincent Rajadurai, et al.
JCO Precision Oncology|January 27, 2025
Clinical Activity of Mitogen-Activated Protein Kinase Inhibitors in Patients With MAP2K1 (MEK1)-Mutated Metastatic CancersMatthew Dankner, Emmanuelle Rousselle, Sarah Petrecca, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Mcgill Journal of Medicine : MJM : an International Forum for the Advancement of Medical Sciences by Students|January 26, 2011
Cracking Cancer with CRKAbicumaran Uthamacumaran, Charles Vincent Rajadurai, Morag Park
Current Oncology (Toronto, Ont.)|November 26, 2024
Evaluating the Efficacy of Immunotherapy in Fragile Hospitalized PatientsCharles Vincent Rajadurai, Guillaume Gagnon, Catherine Allard, et al.
Current Oncology (Toronto, Ont.)|May 26, 2023
An Unconventional Regimen of Carboplatin and Paclitaxel in Metastatic Colorectal Carcinosarcoma: A Case Report and Review of LiteratureChangsu Lawrence Park, Charles Vincent Rajadurai, Tuyet Nhung Ton Nu, et al.
Breast Cancer Research : BCR|December 16, 2014
Breast cancer anti-estrogen resistance 3 inhibits transforming growth factor β/Smad signaling and associates with favorable breast cancer disease outcomesJimin Guo, Lucie Canaff, Charles Vincent Rajadurai, et al.
JCO Precision Oncology|January 27, 2025
Clinical Activity of Mitogen-Activated Protein Kinase Inhibitors in Patients With MAP2K1 (MEK1)-Mutated Metastatic CancersMatthew Dankner, Emmanuelle Rousselle, Sarah Petrecca, et al.
Pageof 1